BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36068379)

  • 21. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
    Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
    BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
    Kobayashi K; Ono Y; Kitano Y; Oba A; Sato T; Ito H; Mise Y; Shinozaki E; Inoue Y; Yamaguchi K; Saiura A; Takahashi Y
    Ann Surg Oncol; 2023 Nov; 30(12):7338-7347. PubMed ID: 37365416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative infectious complications are associated with diminished overall survival of patients undergoing resection for colorectal liver metastases.
    Knitter S; Noltsch AR; Pesthy S; Beierle AS; Krenzien F; Schöning W; Andreou A; Pratschke J; Schmelzle M
    Eur J Surg Oncol; 2023 Sep; 49(9):106920. PubMed ID: 37121813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases.
    Amygdalos I; Hitpass L; Schmidt F; Josephs G; Bednarsch J; Berres ML; Lüdde T; Olde Damink SWM; Ulmer TF; Neumann UP; Bruners P; Lang SA
    Langenbecks Arch Surg; 2023 Aug; 408(1):343. PubMed ID: 37642753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Limited Survival After Resection of Synchronous Colorectal Liver Metastases: a Propensity Score Matched Comparison Between The Primary First And The Simultaneous Strategy.
    Addeo P; Foguenne M; Guerra M; Cusumano C; Paul C; Faitot F; Fiore L; De Mathelin P; Bachellier P
    J Gastrointest Surg; 2023 Jun; 27(6):1141-1151. PubMed ID: 36857012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).
    Tinguely P; Ruiter SJS; Engstrand J; de Haas RJ; Nilsson H; Candinas D; de Jong KP; Freedman J
    Eur J Cancer; 2023 Jul; 187():65-76. PubMed ID: 37119639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
    Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
    J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation.
    Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
    Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
    Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Abdominal Aortic Calcification on Recurrence Following Initial Hepatectomy for Colorectal Liver Metastases.
    Imaoka K; Ohira M; Shimomura M; Hattori M; Bekki T; Sato K; Imaoka Y; Akabane S; Nakano R; Yano T; Sakai H; Hirata F; Kuroda S; Tahara H; Ide K; Ishiyama K; Kobayashi T; Tanaka Y; Ohdan H
    Anticancer Res; 2024 Feb; 44(2):649-658. PubMed ID: 38307553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcome following surgical versus non-surgical treatment of colorectal lung metastasis-a retrospective cohort study.
    Denz A; Hahn V; Weber K; Weber GF; Grützmann R; Krautz C; Brunner M
    Langenbecks Arch Surg; 2024 Apr; 409(1):121. PubMed ID: 38605271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A machine learning model for colorectal liver metastasis post-hepatectomy prognostications.
    Lam CSN; Bharwani AA; Chan EHY; Chan VHY; Au HLH; Ho MK; Rashed S; Kwong BMH; Fang W; Ma KW; Lo CM; Cheung TT
    Hepatobiliary Surg Nutr; 2023 Aug; 12(4):495-506. PubMed ID: 37601005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative disabilities in activities of daily living are associated with worse prognosis after hepatectomy for colorectal liver metastasis.
    Mima K; Hayashi H; Maruno M; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Imai K; Baba H
    HPB (Oxford); 2024 Feb; 26(2):203-211. PubMed ID: 37770363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low visceral fat area on long-term survival of stage I-III colorectal cancer.
    Kamada T; Ohdaira H; Takahashi J; Aida T; Nakashima K; Ito E; Suzuki N; Hata T; Yoshida M; Eto K; Suzuki Y
    Nutrition; 2024 Feb; 118():112302. PubMed ID: 38096604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases.
    Chen ZG; Ji XM; Xu YX; Fong WP; Liu XY; Liang JY; Tan Q; Wen L; Cai YY; Wang DS; Li YH
    Ther Adv Med Oncol; 2024; 16():17588359241230752. PubMed ID: 38425989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Debulking hepatectomy for colorectal liver metastasis: Analysis of risk factors for progression free survival.
    Mazzotta AD; Usdin N; Samer D; Tribillon E; Gayet B; Fuks D; Louvet C; Soubrane O
    Surg Oncol; 2024 Mar; ():102056. PubMed ID: 38531729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
    Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.